North America Cosmetic Surgery Market Overview
North America's cosmetic surgery market size was valued at USD 18.5 billion in 2022. The Cosmetic Surgery market industry is projected to grow from USD 19.3 Billion in 2023 to USD 27.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.50% during the forecast period (2024 - 2032). The growing awareness about available cosmetic procedures is one of the major market drivers driving the Cosmetic Surgery market in North America. Industries are adopting Cosmetic Surgery due to improved accessibility to cosmetic surgery clinics.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Cosmetic Surgery Market Trends
- Growing popularity of non-invasive procedures is driving the market growth.
The North American Cosmetic Surgery market CAGR is expanding due to the growing popularity of non-invasive procedures. Patients are increasingly seeking less invasive alternatives to traditional surgical interventions, driven by factors such as reduced downtime, fewer complications, and a desire for subtle enhancements. Non-invasive procedures, including injectables like Botox and dermal fillers, laser treatments, and chemical peels, are gaining traction due to their convenience and quicker recovery times. Technology advancements have played a major role in developing these non-surgical options, offering patients effective solutions with minimal disruption to their daily lives.
Furthermore, the growth of the Cosmetic Surgery market is influenced by technology. Innovations such as 3D imaging, virtual reality, and artificial intelligence are incorporated into various aspects of cosmetic surgery. Surgeons use 3D imaging to provide more accurate simulations of potential outcomes, allowing patients to visualize results before a procedure. Virtual reality is being utilized for training purposes and patient education. Additionally, artificial intelligence aids in personalized treatment plans, improving surgical precision and enhancing post-operative care. These technological advancements contribute to improved patient experiences and drive the efficiency and effectiveness of cosmetic procedures. Thus driving the Cosmetic Surgery market revenue.
Cosmetic Surgery Market Segment Insights
Cosmetic Surgery Procedure Insights
The North America Cosmetic Surgery market segmentation is based on Surgical procedures and Non-surgical procedures. The surgical procedures segment mostly dominated the market. The surgical procedures, such as breast augmentation, liposuction, rhinoplasty, and facelifts, dominate this segment. Increasing demand for aesthetic enhancements and advancements in surgical techniques contribute to the market's growth, reflecting a thriving landscape for surgical cosmetic interventions in North America.
Figure 1: North America Cosmetic Surgery Market, by Procedure, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Cosmetic Surgery Gender Insights
The North America Cosmetic Surgery market segmentation, based on gender, includes Females and Males. The females category generated the most income. With a growing trend in aesthetic procedures, North American women are seeking various cosmetic enhancements to achieve desired beauty standards and boost self-confidence. The market caters to diverse procedures catering specifically to the female.
Cosmetic Surgery Age Group Insights
The North America Cosmetic Surgery market segmentation, based on age group, includes 18 years & younger, 19 to 34 years, 35 to 50 years, 51 to 64 years, and 65 years & above. The 35 to 50 years category generated the most income. This demographic will likely seek cosmetic procedures to address aging concerns and enhance appearance. Procedures such as facelifts, Botox injections, and body contouring may be popular within this age bracket, reflecting a growing demand for aesthetic enhancements among individuals in their mid-thirties to fifties.
Cosmetic Surgery Provider Insights
The North America Cosmetic Surgery market segmentation, based on provider, includes Hospitals, specialty Clinics, and spa and cosmetic Surgery Centers. The hospitals & specialty clinics category generated the most income. Hospitals offer a comprehensive range of surgical procedures focusing on medical care, while specialty clinics specialize in cosmetic and aesthetic treatments. This segmentation caters to diverse patient needs, providing options for both medical and elective procedures in the dynamic North American cosmetic surgery landscape.
Cosmetic Surgery Country Insights
The rapid expansion of the healthcare infrastructure has resulted in a recent boom in demand for Cosmetic Surgery in North America. In the United States, the largest market in the region, cosmetic procedures like breast augmentation, liposuction, and Botox injections remain popular. The country's advanced healthcare infrastructure and increasing aesthetic consciousness drive market growth. Canada witnesses a surge in demand for non-invasive procedures, such as laser and dermal treatments, focusing on natural-looking results. Mexico, a burgeoning market, attracts medical tourists seeking affordable yet high-quality cosmetic surgeries. The North American cosmetic surgery market is characterized by technological advancements, a rise in the aging population, and a cultural emphasis on beauty standards, fostering continuous innovation and expansion in the aesthetic industry across the region.
Figure 2: NORTH AMERICA Cosmetic Surgery MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Cosmetic Surgery Key Market Players & Competitive Insights
Leading market players are investing majorly in research and development to spread their product lines, which will help the Cosmetic Surgery market grow even more. The participants are also undertaking various strategic activities to spread their footprint with new market developments, including product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. The Cosmetic Surgery industry must offer cost-effective items to spread and survive in a competitive and rising market climate.
Major players in the Cosmetic Surgery market are attempting to raise market demand by investing in research and development operations, including Bausch Health Companies Inc. (Canada), Johnson & Johnson Services, Inc. (MENTOR) (U.S.), AbbVie Inc. (U.S.), Cutera (U.S.), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc. (U.S.), Cynosure (U.S.), Apyx Medical (U.S.) and Long Island Plastic Surgical Group, PC (U.S.).
Key Companies in the Cosmetic Surgery market include
-
Bausch Health Companies Inc. (Canada)
-
Johnson & Johnson Services, Inc. (MENTOR) (U.S.)
-
AbbVie Inc. (U.S.)
-
Cutera (U.S.)
-
Merz Pharma (Germany)
-
GALDERMA (Switzerland)
-
Sientra, Inc. (U.S.)
-
Cynosure (U.S.)
-
Apyx Medical (U.S.)
-
Long Island Plastic Surgical Group, PC (U.S.)
Cosmetic Surgery Industry Developments
August 2022: Airsculpt Technologies only recently introduced AirSculpt Smooth, a cellulite eradication solution approved by the FDA in August 2022. AirSculpt Smooth eliminates stubborn cellulite dimples without using any scalpels, needles, or stitches, which are done under local anesthesia, so patients can return to normal activities within twenty-four to forty-eight hours.
May 2021 saw the launch of PERLE, G.C. Aesthetics Inc.’s next-generation breast implants. The PERLE product line is an advanced line of smooth breast implants with propriety surface technology, GCA’s leading industry gel technology, and improved safety features that have contributed to GCA’s long-term excellent safety record.
February 2021: Merz Pharma propounded the launch of BELOTERO BALANCE + Lidocaine in the U.S. It is a Hyaluronic Acid (HA) filler for etched-in lines & The advantages of lidocaine formulation claim to provide a better finish to filler patients.
January 2021: Pharmaceutical and medical device industry Johnson & Johnson received an FDA green light on one mentor memory gel as a new breast implant for uplifting them.
Cosmetic Surgery Market Segmentation
Cosmetic Surgery Procedure Outlook
-
Surgical Procedures
-
Non-Surgical Procedures
Cosmetic Surgery Gender Outlook
Cosmetic Surgery Age Group Outlook
-
18 years & younger
-
19 to 34 years
-
35 to 50 years
-
51 to 64 years
-
65 years & above
Cosmetic Surgery Provider Outlook
Cosmetic Surgery Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 18.5 Billion |
Market Size 2023 |
USD 19.33 Billion |
Market Size 2032 |
USD 27.49 Billion |
Compound Annual Growth Rate (CAGR) |
4.50% (2023-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2019- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Procedure, Gender, Age Group, Provider, and Region |
Region Covered |
North America |
Countries Covered |
The US, Canada, Mexico, and the Rest of North America |
Key Companies Profiled |
Bausch Health Companies Inc. (Canada), Johnson & Johnson Services, Inc. (MENTOR) (U.S.), AbbVie Inc. (U.S.), Cutera (U.S.), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc. (U.S.), Cynosure (U.S.), Apyx Medical (U.S.) and Long Island Plastic Surgical Group, PC (U.S.) |
Key Market Opportunities |
Advances in cosmetic surgery techniques |
Key Market Dynamics |
Changing societal norms and beauty standards Rising social media influence |
Frequently Asked Questions (FAQ) :
The North America Cosmetic Surgery market size was valued at USD 18.5 Billion in 2022.
The market is projected to grow at a CAGR of 4.50% during the forecast period, 2023-2032.
The key players in the market are Bausch Health Companies Inc. (Canada), Johnson & Johnson Services, Inc. (MENTOR) (U.S.), AbbVie Inc. (U.S.), Cutera (U.S.), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc. (U.S.), Cynosure (U.S.), Apyx Medical (U.S.) and Long Island Plastic Surgical Group, PC (U.S.).
The surgical procedures category dominated the market in 2022.
The female category had the largest share of the market.
The 35 to 50 years category had the largest share in the market.
The hospitals & surgery clinics category had the largest share in the market.